By Hollie Lockwood, Client Success Director, Aspirion
Payers have found another method for reducing reimbursement: the line-item audit. As payers face increasing scrutiny over authorization denials, many are shifting their focus to line-item audits as another mechanism to reduce reimbursement. These audits can result in meaningful charge reductions, creating significant underpayment risk for providers, particularly on high-dollar claims.
Overturning these denials requires more than a standard appeal. Health systems need a strategy grounded in contract expertise, payer policy review, and airtight documentation to protect rightful reimbursement.
Understanding Line-Item Audits
A line-item audit occurs when a payer or third-party vendor reviews specific charges on a hospital claim. These audits differ from traditional denials because they typically focus on high-dollar claims, often those exceeding six figures, and frequently begin with itemized statement requests. Although positioned as validation reviews, they can result in material charge reductions that lower reimbursement and may affect stop-loss, outlier, or other supplemental payment thresholds.
Given how high the stakes are, every audit calls for a disciplined denials management plan. Here are five strategies to help you build one
1. Start with the Contract
The managed care agreement is often the strongest tool available when challenging an audit determination.
First, look at what the contract says about audit rights and limitations, billing and coding requirements, claim adjustment provisions, and audit timelines and notification requirements.
Then consider these key questions:
- Was the audit permitted under the terms of the contract?
- Did the payer perform the audit within the contractually allowed time frame?
- Were required processes followed before adjustments were made?
In many cases, the contract may reveal procedural deficiencies that strengthen the provider’s appeal position.
Proof in practice: In one case, a payer attempted to reduce reimbursement by more than $250,000 based on a line-item audit initiated after the contractually allowed review period had expired. By starting with the managed care agreement, the provider identified clear language limiting the payer’s audit rights to a defined time frame after claim payment. Because the audit was initiated more than 90 days outside that period, the provider argued the review was time-barred under the contract and successfully challenged the adjustment.
That level of precision comes from comparing contract terms directly against actual claims data. Aspirion’s proprietary AI platform, ContractIQ, ingests entire managed care agreements using large language models and analyzes contract terms against specific claims, extracting payment rules without manual intervention and applying payer policies and CMS guidance to identify underpayments and payment variances. Findings are validated by a U.S.-based team of attorneys and clinicians.
2. Validate Audit Findings Against Published Policies
Payers frequently cite billing guidelines or internal policies when denying individual charges. Providers should verify whether those policies are publicly available and contractually enforceable. Keep in mind, a payer policy being published does not necessarily mean it supersedes or modifies the negotiated contract.
Best practices include:
- Reviewing the payer’s provider manual for applicable billing guidance
- Examining published reimbursement and payment policies
- Requesting documentation from the payer’s provider relations representative when policies are not readily available
If the payer relies on unpublished or inaccessible policies, providers may have grounds to challenge the denial, particularly when those policies are not incorporated into the provider agreement. Even when only a small percentage of line items are unsupported, the dollars at issue can be significant on high-value claims.
3. Demand Detailed Audit Documentation
Providers cannot effectively appeal line-item denials without complete information regarding the payer’s rationale and methodology.
Payers should provide an audit findings letter that clearly identifies:
- The charges under review
- The reason for each adjustment or denial
- The methodology used to determine reductions
When that documentation is incomplete or missing—particularly when multiple line items or more than $50,000 in disputed charges are on the table—providers should proactively request it before moving forward with an appeal.
Transparency does more than strengthen a single dispute. To support this review process, Aspirion’s proprietary AI platform, DocIQ, analyzes audit letters at a scale manual processes can’t reach, producing a concise summary of the denied charges and the rationale behind them—or the lack of one—and surfacing the patterns that providers can address through broader revenue cycle improvement.
4. Challenge Every Denied Charge
One of the most common—and most costly—mistakes is addressing only select findings within an audit. Many payers interpret silence as acceptance. If any denied charges are not specifically challenged, the payer may treat those adjustments as undisputed and retain the reduced reimbursement amount.
To maximize recovery opportunities:
- Address every denied line item identified in the audit
- Organize appeal letters using clear headings and categories
- Lead with the strongest and most compelling arguments
- Start with typical denials—experimental/no auth/med nec—as these are most likely the strongest and therefore the most likely to be overturned
- Support each dispute with contract language, clinical documentation, or payer policy references whenever possible
Given the sheer volume of appeals that payers process, concise and strategically organized arguments are far more likely to earn meaningful review.
For complex audits involving dozens of charge lines, AI-powered support raises the ceiling for providers—quickly identifying the relevant clinical evidence, payer policies, and medical literature that back your position. This is particularly beneficial for experimental and medical necessity denials, where success often depends on presenting a well-supported, evidence-based case.
5. Monitor Appeal Deadlines Carefully
Timely filing requirements can quietly sink recovery if they aren’t tracked closely.
Many payers establish appeal periods of 30 to 60 calendar days following the issuance of audit findings; however, these deadlines may differ from timelines outlined in provider contracts or state regulations.
Providers should:
- Identify the applicable deadline immediately upon receiving audit findings
- Document the date the audit letter was received
- Preserve evidence of receipt whenever possible
Additionally, providers should carefully review how filing deadlines are calculated, particularly when the payer measures timeliness from the audit letter date rather than the date of receipt.
Avoiding procedural denials allows organizations to focus resources on disputing the audit findings themselves rather than battling preventable administrative obstacles. Missing a filing window by even a few days can jeopardize recovery on claims worth tens or hundreds of thousands of dollars.
Protecting Reimbursement in an Evolving Audit Environment
As reimbursement scrutiny intensifies, line-item audits are becoming an increasingly common source of payment reductions and underpayment risk for providers. Organizations that achieve the strongest recovery outcomes combine contract expertise, disciplined appeal processes, strong clinical documentation, and technology-enabled analytics to challenge unsupported adjustments effectively. This approach not only improves reimbursement recovery but also strengthens payer accountability and overall denials management performance.
As these audits continue to grow in frequency and complexity, providers need more than a reactive appeals process. They need the right expertise, data, and strategic partner to protect rightful reimbursement. Learn how we can help.
